Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: An LEA study

Bone Marrow Transplantation

Volumn 49, Issue 5, 2014, Pages 709-716

  Bernard, F ^a   Auquier, P ^b   Herrmann, I ^a   Contet, A ^c   Poiree, M ^d   Demeocq, F ^e   Plantaz, D ^f   Galambrun, C ^a   Barlogis, V ^a   Berbis, J ^b   Garnier, F ^b   Sirvent, N ^g   Kanold, J ^e   Chastagner, P ^c   Chambost, H ^a   Michel, G ^a,b  

^a TIMONE HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^c HÔPITAL D ENFANTS   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^e UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

BU; childhood leukemia; late effects; quality of life; TBI; transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; MELPHALAN; IMMUNOSUPPRESSIVE AGENT;

ALOPECIA; ARTICLE; CANCER SURVIVOR; CATARACT; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROWTH DISORDER; HEALTH STATUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; RISK ASSESSMENT; SHORT FORM 36; WHOLE BODY RADIATION; ADOLESCENT; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPARATIVE STUDY; INFANT; LEUKEMIA, MYELOID, ACUTE; MULTICENTER STUDY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; SURVIVOR; TIME;

ADOLESCENT; BUSULFAN; CATARACT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GROWTH DISORDERS; HEALTH STATUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; IRON OVERLOAD; LEUKEMIA, MYELOID, ACUTE; MALE; OVERWEIGHT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; QUALITY OF LIFE; SURVIVORS; TIME; WHOLE-BODY IRRADIATION;

EID: 84900301893     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.3     Document Type: Article

References (38)

1. Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor Study. Blood 2007; 110: 3784-3792
2. Armenian SH, Sun CL, Kawashima T, Arora M, Leisenring W, Sklar CA et al. Longterm health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: A report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood 2011; 118: 1413-1420
3. Cohen A, Bekassy AN, Gaiero A, Faraci M, Zecca S, Tichelli A et al. Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transplant 2008; 41(Suppl 2): S43-S48
4. Faraci M, Bekassy AN, De Fazio V, Tichelli A, Dini G. Non-endocrine late complications in children after allogeneic haematopoietic SCT. Bone Marrow Transplant 2008; 41(Suppl 2): S49-S57
5. Ferry C, Socié G. Busulfan-cyclophosphamide versus total body irradiationcyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: What have we learned? Exp Hematol 2003; 31: 1182-1186
6. Michel G, Bordigoni P, Simeoni MC, Curtillet C, Hoxha S, Robitail S et al. Health status and quality of life in long-term survivors of childhood leukaemia: The impact of haematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 897-904
7. Bordigoni P, Esperou H, Souillet G, Pico J, Michel G, Lacour B et al. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: A Societe Francaise De Greffe De Moelle study. Br J Haematol 1998; 102: 656-665
8. Michel G, Valteau-Couanet D, Gentet JC, Esperou H, Socie G, Mechinaud F et al. Weight-based strategy of dose administration in children using intravenous busulfan: Clinical and pharmacokinetic results. Pediatr Blood Cancer 2012; 58: 90-97
9. Girard P, Auquier P, Barlogis V, Contet A, Poiree M, Demeocq F et al. Symptomatic osteonecrosis in childhood leukemia survivors: Prevalence, risk factors and impact on quality of life in adulthood. Haematologica 2013; 98: 1089-1097
10. Sempé M, Pédron G, Roy-Pernot MP. Auxologie méthodes et séquences. Theraplix (ed.) Paris, 1979
11. Le Meignen M, Auquier P, Barlogis V, Sirvent N, Contet A, Simeoni M-C et al. Bone mineral density in adult survivors of childhood acute leukemia: Impact of hematopoietic stem cell transplantation and other treatment modalities. Blood 2011; 118: 1481-1489
12. Oudin C, Simeoni MC, Sirvent N, Contet A, Begu-Le Coroller A, Bordigoni P et al. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood 2011; 117: 4442-4448
13. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
14. Leplege A, Ecosse E, Pouchot J. Le questionnaire MOS SF-36: Manuel De l'utilisateur et guide d'interprétation des scores. Estem E (ed.) Paris, 2001
15. Reulen RC, Zeegers MP, Jenkinson C, Lancashire ER, Winter DL, Jenney ME et al. The use of the SF-36 questionnaire in adult survivors of childhood cancer: Evaluation of data quality, score reliability, and scaling assumptions. Health Qual Life Outcomes 2006; 4: 77
16. Bresters D, Van Gils IC, Kollen WJ, Ball LM, Oostdijk W, Van Der Bom JG et al. High burden of late effects after haematopoietic stem cell transplantation in childhood: A single-centre study. Bone Marrow Transplant 2010; 45: 79-85
17. Perkins JL, Kunin-Batson AS, Youngren NM, Ness KK, Ulrich KJ, Hansen MJ et al. Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr Blood Cancer 2007; 49: 958-963
18. Sun CL, Francisco L, Kawashima T, Leisenring W, Robison LL, Baker KS et al. Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: A report from the Bone Marrow Transplant Survivor Study. Blood 2010; 116: 3129-3139
19. Khera N, Storer B, Flowers ME, Carpenter PA, Inamoto Y, Sandmaier BM et al. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. J Clin Oncol 2012; 30: 71-77
20. Michel G, Socie G, Gebhard F, Bernaudin F, Thuret I, Vannier JP et al. Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: The impact of conditioning regimen without total-body irradiation-A report from the Societe Francaise De Greffe De Moelle. J Clin Oncol 1997; 15: 2238-2246
21. Socie G, Clift RA, Blaise D, Devergie A, Ringden O, Martin PJ et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: Long-term follow-up of 4 randomized studies. Blood 2001; 98: 3569-3574
22. Palamaras I, Misciali C, Vincenzi C, Robles WS, Tosti A. Permanent chemotherapyinduced alopecia: A review. J Am Acad Dermatol 2011; 64: 604-606
23. Paus R, Haslam I, Sharov A, Botchkarev V. Pathobiology of chemotherapy-induced hair loss. Lancet Oncol 2013; 14: E50-e59
24. Tosti A, Piraccini B, Vincenzi C, Misciali C. Permanent alopecia after busulfan chemotherapy. Br J Dermatol 2005; 152: 1056-1058
25. Lawenda B, Gagne H, Gierga D, Niemierko A, Wong W, Tarbell N et al. Permanent alopecia after cranial irradiation: Dose-response relationship. Int J Radiat Oncol Biol Phys 2004; 60: 879-887
26. Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M et al. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant. Int J Radiat Oncol Biol Phys 2005; 63: 1568-1575
27. Baker KS, Ness KK, Weisdorf D, Francisco L, Sun CL, Forman S et al. Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: A report from the Bone Marrow Transplant Survivor Study. Leukemia 2010; 24: 2039-2047
28. Bernard F, Bordigoni P, Simeoni MC, Barlogis V, Contet A, Loundou A et al. Height growth during adolescence and final height after haematopoietic SCT for childhood acute leukaemia: The impact of a conditioning regimen with BU or TBI. Bone Marrow Transplant 2009; 43: 637-642
29. Inaba H, Yang J, Kaste S, Hartford C, Motosue M, Chemaitilly W et al. Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation. J Clin Oncol 2012; 30: 3991-3997
30. Couto-Silva AC, Trivin C, Esperou H, Michon J, Fischer A, Brauner R. Changes in height, weight and plasma leptin after bone marrow transplantation. Bone Marrow Transplant 2000; 26: 1205-1210
31. Didi M, Didcock E, Davies HA, Ogilvy-Stuart AL, Wales JK, Shalet SM. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. J Pediatr 1995; 127: 63-67
32. De Witte T. The role of iron in patients after bone marrow transplantation. Blood Rev 2008; 22(Suppl 2): S22-S28
33. Sanders JE, Hoffmeister PA, Woolfrey AE, Carpenter PA, Storer BE, Storb RF et al. Thyroid function following hematopoietic cell transplantation inchildren: 30 years' experience. Blood 2009; 113: 306-308
34. Berger C, Le-Gallo B, Donadieu J, Richard O, Devergie A, Galambrun C et al. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant 2005; 35: 991-995
35. Socié G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18: 348-357
36. Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM et al. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood 2011; 117: 316-322
37. Sanders JE, Hoffmeister PA, Storer BE, Appelbaum FR, Storb RF, Syrjala KL. The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplant 2010; 45: 746-754
38. Löf CM, Winiarski J, Giesecke A, Ljungman P, Forinder U. Health-related quality of life in adult survivors after paediatric allo-SCT. Bone Marrow Transplant 2009; 43: 461-468.